Synergistic effect of ubiquitin on lipopolysaccharide-induced TNF-α production in murine macrophage cell line RAW 264.7 cells

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1450, Issue 1, 1999, Pages 25-34

  Nabika, Toumei ^a   Terashima, Masaharu ^a   Momose, Isamu ^a   Hosokawa, Yu ^b   Nagasue, Naofumi ^a   Tanigawa, Yoshinori ^a  

^a SHIMANE UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Lipopolysaccharide; Macrophage; Tumor necrosis factor ; Ubiquitin

Indexed keywords

LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; DRUG DEGRADATION; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VITRO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA SYNTHESIS; TRANSCRIPTION REGULATION;

ANIMALS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; UBIQUITINS;

MURINAE;

EID: 0032956716     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4889(99)00024-5     Document Type: Article

References (47)

1. Pancré V., Auriault C., Joseph M., Cesbron J.Y., Kusnierz J.P., Capon A. A suppressive lymphokine of platelet cytotoxic functions. J. Immunol. 137:1986;585-591.
2. Knight E. Jr., Cordova B. IFN-induced 15-kDa protein is released from human lymphocytes and monocytes. J. Immunol. 146:1991;2280-2284.
3. Nakamura M., Ogawa H., Tsunematsu T. Isolation and characterization of a monoclonal nonspecific suppressor factor (MNSF) produced by a T cell hybridoma. J. Immunol. 136:1986;2904-2909.
4. Pancré V., Pierce R.J., Fournier F., Mehtali M., Delanoya A., Capron A., Auriault C. Effect of ubiquitin on platelet functions: possible identity platelet activity suppressive lymphokine (PASL). Eur. J. Immunol. 21:1991;2735-2741.
5. Nakamura M., Xavier R.M., Tanigawa Y. Ubiquitin-like moiety of the monoclonal nonspecific suppressor factor β is responsible for its activity. J. Immunol. 156:1996;533-538.
6. D' Cunha J., Knight E. Jr., Haas A.L., Truitt R.L., Borden E.C. Immunoregulatory properties of ISG15, an interferon-induced cytokine. Proc. Natl. Acad. Sci. USA. 93:1996;211-215.
7. Narasimhan J., Potter J.L., Haas A.L. Conjugation of the 15-kDa interferon-induced ubiquitin homolog is distinct from that of ubiquitin. J. Biol. Chem. 271:1996;324-330.
8. Nakamura M., Ogawa H., Tsunematsu T. Characterization of monoclonal nonspecific suppressor factor (MNSF) with the use of a monoclonal antibody. J. Immunol. 138:1987;1799-1803.
9. Nakamura M., Xavier R.M., Tanigawa Y. Monoclonal nonspecific suppressor factor (MNSF) inhibits the IL-4 secretion by bone marrow-derived mast cell (BMMC). FEBS Lett. 39:1994;239-242.
10. Nakamura M., Ogawa H., Tsunematsu T. Mode of action of monoclonal nonspecific suppressor factor (MNSF) produced by murine hybridoma. Cell. Immunol. 116:1988;230-239.
11. Bercovich B., Stancovski I., Mayer N., Blumenfeld N., Laszlo A., Schwartz A.L., Ciechanover A. Ubiquitin-dependent degradation of certain protein substrates in vitro require the molecular chaperone Hsc70. J. Biol. Chem. 272:1997;9002-9010.
12. Mayer R.J., Arnold J., László L., Landon M., Lowe J. Ubiquitin in health and disease. Biochim. Biophys. Acta. 1089:1991;141-157.
13. Asseman C., Pancré V., Delanoye A., Capron A., Auriault C. A radioimmunoassay for the quantification of human ubiquitin in biological fluids: application to parasitic and allergic diseases. J. Immunol. Methods. 173:1994;93-101.
14. Goldstein G., Schid M., Hammerling U., Boyse E., Schlesinger D., Niall H. Isolation of a polypeptide that has lymphocyte-differentiating properties and is probably represented universally in living cells. Proc. Natl. Acad. Sci. USA. 72:1975;11-15.
15. Mijatovic T., Kruys V., Caput D., Defrance P., Huez G. Interleukin-4 and-13 inhibit tumor necrosis factor-α mRNA translational activation in lipopolysaccharide induced mouse macrophages. J. Biol. Chem. 272:1997;14394-14398.
16. Garcia I., Miyazaki Y., Araki K., Araki M., Lucas R., Grau G.E., Milon Y., Montixi C., Lesslauer W., Vassalli P. Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogens and Leishmania major infections. Eur. J. Immunol. 25:1995;2401-2407.
17. Goldfeeld A.E., Tsai E.Y. TNF-α and genetic susceptibility to parasitic disease. Exp. Parasitol. 84:1996;300-303.
18. Suzuki K., Nakamura M., Nariai Y., Dekio S., Tanigawa Y. Monoclonal nonspecific suppressor factor β (MNSFβ) inhibits the production of TNF-α by lipopolysaccharide-activated macrophages. Immunobiology. 195:1996;187-198.
19. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1986;11447-11453.
20. Nahli L.O., Philo J.S., Li T., Zhang M., Samal B., Arakawa T. Induction of α helix in the β-sheet protein tumor necrosis factor-α: thermal and trifluoroethanol-induced denaturation at neutral pH. Biochemistry. 35:1996;11447-11453.
21. Makhatadze G.I., Clore G.M., Gronenborn A.M., Privalov P.L. Thermodynamics of unfolding of the all β-sheet protein interleukin-1 β Biochemistry. 33:1994;9327-9332.
22. Filippis V.D., de Laureto P.P., Toniutti N., Fontana A. Acid-induced molten globule state of a fully active mutant of human interleukin-6. Biochemistry. 35:1996;11503-11511.
23. Shanwell A., Kristiansson M., Remberger M., Ringden O. Generation of cytokin red cell concentrates during storage is prevented by prestorage white cell reduction. Transfusion. 37:1997;678-684.
24. Kriegler M., Perez C., DeFay K., Albert I., Lu S.D. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell. 53:1988;45-53.
25. Pennica D., Nedwin G.E., Hayflick J.S., Seebury P.H., Derynck R., Palladino M.A., Kohr W.J., Aggarwall B.B., Goeddel D.V. Human tumor necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature. 312:1984;724-729.
26. Shirai T., Yamaguchi T., Ito H., Todd C.W., Wallace R.B. Cloning and expression in Escherichia coli of the gene for human tumor necrosis factor. Nature. 313:1985;803-806.
27. Luetting B., Decker T., Lohmann-Matthes M.L. Evidence for the existence of two forms of membrane tumor necrosis factor: an integral protein and a molecule attached to its receptor. J. Immunol. 143:1989;4034-4038.
28. Perez C., Albert I., Defay K., Zachariades N., Gooding L., Kriegler M. A nonsecretable cell surface mutant of tumor necrosis factor(TNF) kills by cell-to-cell contact. Cell. 63:1990;251-258.
29. Jue D.M., Sherry B., Luedke C., Manogue K.R., Cerami A. Processing of newly synthesized cachectin/tumor necrosis factor in endotoxin-stimulated macrophages. Biochemistry. 29:1990;8371-8377.
30. Muller R., Marmenout A., Fiers W. Synthesis and maturation of recombinant human tumor necrosis factor in eukaryotic systems. FEBS Lett. 197:1986;99-104.
31. Jentsch S., McGrath P., Varshavsky A. The yeast DNA repair gene RAD 6 encodes a ubiquitin-conjugating enzyme. Nature. 329:1987;131-134.
32. Glotzer M., Nurray A.W., Kirschner M.W. Cyclin is degraded by the ubiquitin pathway. Nature. 349:1991;132-138.
33. Finly D., Bartel B., Varshavsky A. The tail of ubiquitin precursors are ribosomal proteins whose fusion to ubiquitin facilitate ribosome biogenesis. Nature. 338:1989;394-401.
34. Palombella V.J., Rando O.J., Goldberg A.L., Maniatis T. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell. 78:1994;773-785.
35. Joseph M., Auriault C., Capron A., Vorng H., Viens P. A new function for platelets: IgE-dependent killing of schistosomes. Nature. 303:1983;810-812.
36. Joseph M., Ameisen J.C., Kusnierz J.P., Pancré V., Capron M., Capron A. Participation du recepteur pour IgE a la toxicite des plaquettes sanguines contre les schistosomes. C.R. Acad. Sci. Paris. 298:1984;55-60.
37. Joseph M., Capron A., Ameisen J.C., Capron M., Vorng H., Pancré V., Kusnierz J.P., Auriault C. The precursor for IgE on blood platelets. Eur. J. Immunol. 16:1986;306-312.
38. Teppo A.-M., Maury C.P.J. Radioimmunoassay of tumor necrosis factor in serum. Clin. Chem. 33:1987;2024-2027.
39. A.J.H. Gearing, P. Beckett, M. Christodoulou, M. Churchill, J. Clements, A.H. Davidson, A.H. Drummond, W.A. Galloway, R. Gilbert, J.L. Gordon, T.M. Leber, M. Mangan, K. Miller, P. Nayee, K. Owen, S. Patel, W. Thomas, G. Wells, L.M. Wood, K. Woolley, Processing of tumor necrosis factor-α precursor by metalloproteinases, Nature 370 (1994) 555-557.
40. McGeehan G.M., Becherer J.D., Bast R.C. Jr., Boyer C.M., Champion B., Connolly K.M., Conway J.G., Furdon P., Karp S., Kidao S., McElroy A.B., Nichols J., Pryzwansky K.M., Schoenen F., Sekut L., Truesdale A., Verghese M., Warner J., Ways J.P. Regulation of tumor necrosis factor-α processing by a metalloproteinase inhibitor. Nature. 370:1994;558-561.
41. Mohler K.M., Sleath P.R., Fitzner J.N., Cerretti D.P., Alderson M., Kerwar S.S., Torrance D.S., Otten-Evans C., Greenstreet T., Weerawarna K., Kronheim S.R., Petersen M., Gethart M., Koxlosky C.J., March C.J., Black R.A. Protection against a lethal dose of endotoxin by an inhibitor of tumor necrosis factor processing. Nature. 370:1994;218-220.
42. Black R.A., Rauch C.T., Kozlosky C.J., Peschon J.J., Slack J.L., Wolfson M.F., Castner B.J., Stocking K.L., Reddy P., Srinivasan S., Nelson N., Boiani N., Schooley K.A., Gerhart M., Davis R., Fitzner J.N., Johnson R.S., Paxton R.J., March C.J., Cerretti D.P. A metalloproteinase disintegrin that release tumor necrosis factor-α from cells. Nature. 385:1997;729-733.
43. Pahan K., Sheikh F.G., Namboodiri A.M., Singh I. Inhibitor of protein phosphatase 1 and 2A differentially regulate the expression of inducible nitric-oxide synthase in rat astrocytes and macrophages. J. Biol. Chem. 273:1998;12219-12226.
44. Nathan C.F. Secretory products of macrophages. J. Clin. Invest. 79:1987;319-326.
45. Billiau A., Vanderkerckhove F. Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock. Eur. J. Clin. Invest. 21:1991;559-573.
46. Liovera M., Carbo N., Garcia-Martinez C., Costelli P., Tessitore L., Baccino F.M., Agell N., Bagby G.J., Lopez-Soriano F.J., Argiles J.M. Anti-TNF treatment reverts increased muscle ubiquitin gene expression in tumor-bearing rats. Biochem. Biophys. Res. Commun. 221:1996;653-655.
47. Liovera M., Garcia-Martinez C., Agell N., Lopez-Soriano F.J., Argiles J.M. TNF can induce the expression of ubiquitin-dependent proteolytic system in rat soleus muscles. Biochem. Biophys. Res. Commun. 230:1997;238-241.